Skip to main content

Cresset Asset Management, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1761013 Chicago, IL

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$16,764,828
+$1,776,109 QoQ
Shares Held
259,397
+16.5% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 99.1699981110036.ToString("F0")% Shared 0.ToString("F0")% None 0.8300018889964033.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Cresset Asset Management, LLC holds $83,905,083 across 42 Biotechnology names. HALO ranks #2 (20.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 HALO
Halozyme Therapeutics, Inc.
This page
259,397 $16,764,828

All Filings in HALO

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,764,828 259,397
2025-12-31 $14,988,719 222,715
2025-09-30 $16,402,491 223,650
2025-06-30 $15,067,957 289,657
2025-03-31 $19,549,533 306,371
2024-12-31 $15,936,698 333,334
2024-09-30 $19,124,628 334,113
2024-06-30 $15,196,076 290,223
2024-03-31 $11,420,950 280,751
2023-12-31 $7,683,910 207,898
2023-09-30 $6,875,503 179,987
2023-06-30 $3,807,116 105,548